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2Abstract
The ability to control gene expression has traditionally been pursued at the protein 
level, using drugs designed to mimic a natural substrate or to disrupt a protein’s active 
site. Traditional drug targeting by competitive and non-competitive inhibitors, however, 
requires a fairly detailed knowledge of the target protein’s three-dimensional structure. 
More recently, focus has broadened to include alternative methods of genetic control, 
including the use of single-stranded DNA or RNA probe sequences which control gene 
expression by targeting the genes themselves. Within the last two decades, peptide 
nucleic acids (PNAs) – DNA mimics possessing natural bases linked to an N-(2-
aminoethyl)-glycine (AEG) backbone – have proven as effective in gene-targeting as 
traditional synthetic DNA or RNA with the added advantages of tighter binding and 
greater specificity. Additionally, PNAs are not easily recognized by nucleases, proteases, 
and peptidases giving them greater resistance to enzyme degradation and making them 
even more favorable for gene targeting in vivo.
Traditional PNA triplexes are composed of two polypyrmidine PNA strands 
bound to the Watson-Crick and Hoogsteen faces, respectively, of the polypurine strand of 
target DNA after displacing the polypyrimidine strand of the original DNA duplex. Janus 
Wedge (JW) residues, on the other hand, utilize unnatural bases linked to the AEG 
backbone, which are capable of hydrogen bonding to the Watson-Crick faces of both 
strands of a target DNA duplex. JW triplex formation, then, has a DNA2-PNA 
stoichiometry, and no Hoogsteen face interactions.
The generalization of the DNA duplex targeting strategy by peptide oligomers
requires substantial discoveries in the field of PNA research, including an understanding 
3of the three-dimensional structure and folding pattern of these triple-stranded molecules. 
This report details the crystallization efforts on JW DNA-peptide-DNA triplexes using 
11dC811-11T811 target sequences – with and without single base overhangs – and 
synthetic W8K peptide. Hanging drop vapor diffusion methods showed that while crystal 
formation was extremely elusive, in narrowing the optimal buffer conditions, 25% PEG 
concentration was consistently correlated with the most promising crystallization efforts 
for both the overhanged and non-overhanged sequences. 
Introduction
The field of triple stranded DNA research traces its lineage back to Felsenfeld et 
al. who is believed to have made the first discovery of a triple stranded molecule in 
1957.1 While studying the complexing reaction of synthetic polyadenylic acid (poly-A) 
and polyuridylic acid (poly-U) in aqueous solution, a complex was discovered with a 
sedimentation coefficient significantly greater than the 1:1 duplex. Subsequent analysis 
of this new complex revealed that its formation was optimized by a U2:A base ratio in 
solution, suggesting a poly(U-A-U) triplex, which Felsenfeld postulated was the result of
binding of a single poly(U) strand to a poly(A-U) duplex in the helical groove. He 
proposed that additional hydrogen bonds with one or both members of the Watson-Crick 
(W-C) duplex provided stability for the three-stranded molecule.
The next major breakthrough in the field of DNA triplexes came over two 
decades later when Lee et al. expanded on their previous finding that cytosine could form 
a triple stranded complex with a cytosine-guanine duplex only if it was protonated – a 
requirement which restricts C+-G-C formation to pHs below 6.2 The modified residue 5-
methylcytosine (m5C), however, could form a stable m5C-G-C triplex at neutral pH (pH 
48.0).3 Based on these findings, Lee proposed methylation of cytosine as one method of 
controlling triplex stability. Both C+-G-C and m5C-G-C triplexes form from the binding 
of an additional polypyrimidine (py) strand to the polypurine (pu) strand of a
polypurine•polypyrimidine duplex – a finding consistent with Felsenfeld’s research. 
The preference for py-pu-py triplex formation rather than pu-py- pu stems from 
the chemical properties of the central nucleotide. While participating in W-C base 
pairing, purines have a second binding face, known as the Hoogsteen face, exposed for 
additional hydrogen bonding interactions with a second pyrimidine base (Figure 1). 
Figure 1: Hydrogen Bonding at Watson-Crick and Hoogsteen 
faces of C+-G-C and U-A-U Triplexes4
When DNA duplexes fold into their traditional B-form helices, the Hoogsteen face of 
purines is accessible in the major groove. This conformation suggests a mechanism for 
interaction between the polypurine of duplex DNA and a polypyrimidine5 (i.e. T-A-T) or 
polypurine6 (i.e. A-A-T) probe strand, with the polypurine strand forming a second set of 
hydrogen bonds with the single strand entering in the major groove. Pyrimidines, 
however, lack a Hoogsteen face, preventing the formation of similar bidentate 
interactions, and explaining the preference for py-pu-py, rather than pu-py- pu, triplexes. 
The obvious downside of these types of triplexes is that they are limited to polypurine 
5targets, which stands as a significant obstacle to the generalized recognition motif 
necessary for eventual application to natural, rather than synthetic, DNA target 
sequences.
In addition to natural and modified DNA oligonucleotides, it was discovered that 
third strand binding could be accomplished by DNA mimics, known as peptide nucleic 
acids (PNAs). Structurally, PNAs possess a backbone consisting of repeating AEG 
monomers linked by peptide bonds (Figure 2). Like DNA, PNAs use natural purine and 
pyrimidine bases (A, T, C, and G) linked to the peptide backbone by methylene carbonyl 
bonds. However, unlike DNA, PNAs lack any pentose sugars and phosphate groups 
making them more resistant to DNA degradation enzymes such as nucleases and 
proteases. 
Figure 2: Structural Comparison of DNA and PNA Backbone7
6PNAs are also stable over a large pH range, and the neutrality of their peptide backbone 
minimizes charge-charge repulsion interactions with DNA phosphate groups. For all 
these reasons, PNAs have emerged as a desirable alternative to DNA and RNA for 
studies of triple helix formation.
PNA triplexes form by a strand invasion mechanism beginning with the 
displacement of the polypyrimidine strand of a DNA duplex target by a polypyrimidine 
PNA probe strand. Watson-Crick hydrogen bonds between the bases of the PNA and 
polypurine strand stabilizing the formation of a PNA/DNA double helix. When folded, 
the Hoogsteen face of the polypurine strand lies exposed in the major groove, to which a 
second polypyrimidine PNA strand binds to complete the PNA- DNA-PNA triplex, while 
the displaced polypyrimidine DNA strand remains in the characteristic D-loop 
conformation (Figure 3).
Figure 3: Strand Invasion by a PNA to Form PNA-DNA- PNA Triplex and D-Loop8
7Bearing some similarities to traditional PNAs, Janus Wedge (JW) triplexes – a 
formation first suggested by Lehn in his work with heterocycles9 – represent a 
fundamentally new approach to duplex DNA targeting. JW residues are structurally 
composed of an AEG peptide backbone linked by methylene carbonyl bonds to their 
respective bases. Unlike traditional PNAs which utilized the natural A, G, T, and C bases, 
JW residues contain unnatural bases chemically synthesized to be able to hydrogen bond 
with the Watson-Crick faces of two different natural bases (see Figure 4). Appropriately,
JW triplexes are named for the Roman god Janus, who is traditionally depicted with two 
faces – one looking ahead at the future and one looking behind at the past. 
Figure 4: Hydrogen Bond Interactions of DNA-PNA-DNA 
Triplex at Watson-Crick Faces of DNA Bases10
The seemingly minor change from natural to unnatural bases in JW residues 
results in an entirely novel triplex and mechanism of formation. Unlike PNAs which bind 
to the polypurine of duplex DNA and displace the polypyrimidine during strand invasion,
JW residues form hydrogen bonds with the W-C faces of both strands of the target DNA 
following insertion into the duplex. As a result of this increased number of hydrogen 
bonds, JW triplexes are proposed to be more stable relative to the DNA duplex. Unlike 
8traditional PNAs which are PNA-DNA-PNA triplexes, JW triplexes bind with 
DNA2:PNA stoichiometry. Finally, JW triplexes are distinguished from traditional PNA 
triplexes in that no Hoogsteen face is involved in the final triple-stranded complex
Previous research conducted by Chen et al. under the supervision of Larry 
McLaughlin has elucidated several important characteristics of JW triplexes on which 
this research builds.11 Their work focused on a 30-nucleotide synthetic duplex containing 
a non-complementary (C8-T8) target sequence flanked by eleven complementary W-C 
base pairs (Figure 5, next page). The non-complementary target ensured JW triplex 
formation did not need to compete with the duplex form, which would occur for 
complementary targets. The JW peptide probe was synthesized from eight repeating N6-
amino-pseudocytidine (W) residues linked to an L-lysine (K) residue, and attached to an 
AEG backbone. They showed that the W8K oligomer binds to both DNA strands 
individually by gel shift assay, but could not confirm the nature of the binding. Their 
work also suggested that, similar to traditional PNA triplexes, JW insertion occurs in the 
major groove of the target duplex. Also, thermodynamic studies confirmed that triplex 
formation occurs with binding to both strands of the DNA duplex, and revealed that the
JW triplex is more stable than DNA-DNA-DNA or hairpin triplexes. 
Figure 5: 11dC811-11dT811 DNA Duplex Target Sequence12
9In light of their potential as gene-targeted drugs, the conformation and folding of 
DNA-, RNA-, and PNA-containing triplexes are of growing importance to researchers. In 
1997, Rasmussen et al. successfully crystallized two self-complementary PNAs, H-
CGTACG-NH2 and H-CGBrUACG-NH2, using the hanging drop vapor diffusion method 
(see “Materials and Methods” section for detail).13 Crystals were diffracted to 1.7 Å 
resolution by x-ray crystallography. The PNA-PNA duplex was found to adopt a unique 
helical structure stabilized by eighty-two water molecules forming bridges between 
purine-N3 or pyrimidine-O2 and backbone amide N at each base step. The structure was 
believed to support the belief that the natural bases prefer stacking in A-like helices. 
Mismatch analysis confirmed W-C base pairing rules were followed throughout the helix. 
The hanging drop vapor diffusion method was also employed by Kastrup et al. to 
crystallize a DNA-PNA duplex at about 5 Å resolution.14 When compared to the typical 
B-form DNA duplex, their experiments revealed that PNA is almost a perfect structural 
mimic of DNA. The DNA-PNA helix is structurally similar to a B-form helix, and like 
the PNA-PNA self-complementary duplex, it was found to obey the W-C base pairing 
rules throughout the helix. 
Crystallization efforts on peptide nucleic acid triplexes have been focused 
primarily on traditional PNA-DNA-PNA triplexes. Betts et al., for example, successfully 
crystallized a triplex consisting of a polypurine DNA strand complexed to a 
polypyrimidine hairpin PNA15 . Conformationally, the triplex was found to be unique 
among previously known nucleic acid structures, and was designated as P-form, thereby 
expanding the number of stable helical forms which nucleic acids may adopt. Despite the 
progress made in crystallizing traditional PNA triplexes, Janus Wedge triplexes have 
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proven much more difficult to crystallize and x-ray analysis of JW triplexes is not well 
documented. Considering the potential of PNAs for transcriptional control of gene 
expression coupled with the unique mechanism of insertion and triplex formation used by 
Janus Wedge PNAs, the pressure is on to obtain three-dimensional data of these DNA-
PNA-DNA structures through x-ray crystallography.
Materials and Methods
Chemicals and Materials: The phosphoramidites and reagents for DNA synthesis 
were purchased from Glen Research. Polyethylene glycol (PEG) 4000, 6000, 8000, and 
10000 were purchased from Fluka. Spermine and spermidine were purchased from
Sigma-Aldrich. Crystallization plates and siliconized coverslips were purchased from
Hampton Research. 0.22 µm centrifugal filtration devices were purchased from Millipore. 
Spermine Tetrahydrochloride was purchased from United States Biochemical (USB). 2-
methyl-2,4-pentanediol (MPD) was purchased from Sigma-Aldrich. Synthesized and 
purified M1-219 JW peptide was obtained from post-doctorate researcher Meena. 2-
amino-pyrimidine substituted Dickerson dodecamer DNA was obtained from post-
graduate researcher Zhenhua.
DNA Synthesis: Single strand DNA sequences were synthesized using an Applied 
Biosystems 394 DNA/RNA Synthesizer from standard dNTP monomers (sequences 
listed in Appendix C). Syntheses were carried out on a 1.0 µmol scale with 30-35 mg of 
the 3’ terminal dNTP added as starting material to the column. Chemically, these 3’ 
terminal monomers were bound to a controlled pore glass (CPG) solid support at the 3’ 
position, and blocked with a dimethoxytrityl (DMT) group at the 5’ position. Synthesis 
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proceeded with 3’  5’ directionality following the generalized assembly pathway 
depicted in Appendix A16, with capping of unreacted dNTPs after each coupling step. 
Final sequence purity was consistently over 98% (measured relative to the amount of 
reacted sequence after the first coupling). 
DNA Isolation and Purification: The synthesized DNA oligomers were first dried 
under line vacuum for 3-5 minutes and transferred to eppendorf tubes. ~2 mL of 
concentrated ammonium hydroxide (NH4OH) were added to each tube, which were then 
placed in a 55°C water bath for 8-10 hours. Ammonium hydroxide treatment 
accomplishes three tasks: 1.) strand cleavage from CPG support, 2.) removal of exocyclic 
amine protecting groups on C, G, and A bases, and 3.) removal of cyanoethoxy protecting 
groups on the backbone phosphates. Passing the solutions through cotton-plugged glass 
pipettes filtered out the CPG, and then the volumes were reduced under high vacuum to < 
1 mL. The oligomers were syringe-filtered (0.22 µm) using several mL of dH2O as wash. 
Purification was begun by high performance liquid chromatography (HPLC) using a 
Semi Prep C18 (OliR3) reversed phase column measuring absorbance at 254.0 nm. Prior 
to connecting the HPLC lines, Buffer A (50 mM TEA) and Buffer B (50 mM TEA, 70% 
acetonitrile) were vacuum filtered through a Millipore 0.45 micron HA filter to remove 
microparticles and degas the solutions. The HPLC cycle alternated between a 5 minute 
column conditioning (POROSHQ20Wash) and a 12 minute injection (oliR3). Next, 
detritylation (removal of DMT group) was achieved by addition of ~2 mL of 80% acetic 
acid in H2O to the oligomers, which were placed on ice for 20 minutes. The acetic acid 
was evaporated, followed by 2-3 co-evaporations with 10 mL of ethanol , under high 
vacuum using a rotary evaporator (rotovap). Detritylated oligomers were desalted using a
12
Sephadex G-10 column, flash frozen by immersion in liquid N2, and finally lyophilized
overnight. Sample concentration was determined by UV spectroscopy at 254.0 nm. 5 µL 
of the DNA oligomer were diluted to 1.0 mL with dH2O, representing a 200-fold dilution, 
prior to spectrophotometer detection, and the sample concentration was calculated by the 
equation:
200 * Absorbance =  extinction coefficient * path length * concentration
A table of pertinent extinction coefficients is included as Appendix B.
Peptide Synthesis17: Cbz protected 2,4-diamino 6-oxo pyrimidine monomer (Figure 
6) having an ethylene glycyl backbone was synthesized in six steps and was characterized 
by NMR (Nuclear Magnetic Resonance) and HRMS (High Resolution Mass 
Spectrometry). Sequential assembly of L-Lys and JW monomers on MBHA (4-
Methylbenzhydryl Amine) resin using standard peptide coupling protocol provided the 
protected oligomer, which was cleaved from the support using the TFMSA cleavage 
Figure 6: Peptide Synthesis Starting 
Material: Cbz-protected 2,4-diamino-6-
oxo-pyrimidine
Figure 7: Structure of Peptide Nucleic 
Acid M1-219
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method to obtain free peptide nucleic acid, M1-219 (Figure 7, previous page). The 
peptide was purified by HPLC using a Semi Prep C18 reversed phase column and was 
characterized by MALDI TOF. The calculated mass for C18H127N51O25 was determined to 
be 2275.2 Da, and the observed mass was 2275.2 Da.
Gel Electrophoresis: The synthesized DNA was annealed and checked by gel 
electrophoresis for proper duplex and/or triplex formation. After calculating the amount 
of DNA or peptide needed for a gel or crystallization plate, these volumes were aliquoted 
into eppendorf tubes and dried under high vacuum in a Jouan RC 10.22 speedvac. Dried 
samples were resuspended with the appropriate volume of annealing buffer, and added to 
a beaker containing ~1000 mL of 90-100°C water. After cooling to room temperature, the 
beaker and samples were transferred to a 4°C environment. Samples were run on a 20% 
(19:1 acrylimide:bis-acrylimide) non-denaturing gel washed for 30 minutes at 150 V 
(constant voltage) with 1X TBE (Tris-Borate-EDTA) buffer. The volume of DNA 
solution loaded into each lane was determined by standardizing to a 0.5 absorbance for
the sample. Loading buffer containing 30% glycerol (otherwise identical to the annealing 
buffer) was added to each sample prior to loading on the gel. Gels were run at 250 V 
(constant voltage) for 15-17 hours with 1X TBE buffer. Gels were stained with ethidium 
bromide for 10 minutes and visualized using Bio-Rad Molecular Imager FX using an 
ethidium bromide filter. As a precaution, prior to crystallization work, triplex DNA was 
filtered through a 0.22 µm Ultrafree-MC centrifugal filter at 10,000 rpm to remove 
microparticles.
Hanging Drop Vapor Diffusion: Although there are several methods for 
crystallizing macromolecules, vapor diffusion methods, first used to crystallize tRNA,18
14
have emerged as one of the most popular and successful, particularly when working with
small volumes. To make a plate, a reservoir solution is prepared containing buffer
(sodium cacodylate, specific pH), crystallizing agent or precipitant (PEG), and additives 
(zinc acetate, magnesium acetate, ammonium acetate), and a small volume of this 
solution is mixed with a small volume of macromolecule-containing solution on a 
siliconized glass coverslip. This droplet is sealed by a ring of silicone grease over the 
reservoir, containing a higher concentration of precipitant, and the gradual equilibration 
of the two solutions promotes the crystallization process. Crystallization experiments 
were performed using 24-well Linbro boxes and 22 mm siliconized glass slides at 4°C. 
Results and Discussion
JT Sequences: The JT sequences shown in Appendix C were designed to have a non-
complementary T8-C8 target sequence flanked by complementary 11-base pair segments.
The base composition and purity of the single strands was confirmed by gel 
electrophoresis (see Figure 4, next page). A 300 µM sample of single-stranded JT-2 and 
JT-3 was loaded into lanes 1 and 2, respectively, whose bands corresponded to low 
molecular weight, non-identical species. A single band corresponding to a higher 
molecular weight species in lane 3 containing both JT-2 and JT-3 confirms duplex 
formation occurs with a high degree of efficiency. Lane 5, containing JT-2, JT-3, and 1.0 
equivalents of M1-219 peptide, shows a slight duplex band, and a second higher 
molecular weight species corresponding to DNA-PNA- DNA triplex (lane 4 was blank). 
Single-stranded and duplex DNA were annealed with 10 mM HEPES, pH 7.0 with 50 
mM NaCl and 10 mM MgCl2. Triplex DNA was annealed with 10 mM HEPES, pH 7.0 
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and 1 mM spermidine – an additive used for its ability to stabilize the negative charges of 
the phosphate backbone. 
The first crystallization plate was prepared from this 300 µM sample of JT-2 + 
JT-3 + M1-219 peptide (JT-2+3+p) annealed with 10 mM HEPES, pH 7.0, 1.0 mM 
spermidine. The reservoir conditions of the 24 wells are included in Appendix D, with 
each well containing a unique combination of pH, PEG molecular weight, and PEG 
concentration. The reservoirs contained 1 mL of buffer each, and each droplet contained 
1 µL of triplex solution mixed with 1 µL of reservoir buffer. Immediately after plating the 
samples, all wells appeared as clear drops under a microscope. After three days, 
precipitates had formed in all the wells except the four wells containing 30% PEG 8000, 
regardless of pH, which displayed a combination of precipitate and some microcrystals. 
Figure 8: JT-2+3 Duplex (lane 3) and JT-2+3+p Triplex Formation (lane 5) at 300 µM  
 JT Triplex
 JT Duplex
  JT-2 Single Strand 
  JT-3 Single Strand 
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The largest microcrystals were present in well 23, containing 30% PEG 8000, pH 7.5. 
These four wells showed no significant change up to one month after plate preparation, 
but after three months, the solution in well 23 had precipitated completely and 
microcrystals were no longer present, although the solutions in wells 5, 11, and 17 were 
unchanged. 
This initial promise of PEG 8000 prompted the design of a second crystallization 
plate which focused exclusively on this molecular weight. However, as shown in 
Appendix E, the JT-2+3+p triplex concentration became one of the variables under 
investigation as samples of 200, 225, 250, and 300 µM were annealed (see Figure 9, next 
page). The intensity of the duplex band indicated the formation of a large amount of JT 
duplex despite the presence of peptide in solution. To promote triplex, rather than duplex, 
formation, 20% more peptide was added to each triplex sample, and as shown in Figure 
10 (next page), the concentration of JT duplex decreased while the intensity of the JT 
triplex band increased as desired. The annealing buffer, temperature, drop volume, drop 
composition, and reservoir volume were held consistent with Plate 1. Interestingly, the 
200 µM triplex precipitated immediately after plating, while the remaining three 
concentrations were clear droplets. After one week, precipitation was observed in all 24 
wells, regardless of complex concentration, indicating that new adjustments to the 
crystallization variables must be tested. 
The third crystallization plate tested the hypothesis that crystal formation was 
dependent upon the volume of buffer in the reservoir, the ratio between drop volume and 
reservoir volume, or both. Because lower sample concentrations proved unsuccessful in 
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Figure 9: JT-2+3+p Triplex Formation with 1:1 PNA Equivalents
Figure 10: JT-2+3+p Triplex Formation with 1.2 PNA Equivalents
Plate 2, complex concentration was increased to 400 µM hoping that a higher 
concentration would improve yield, and 1.7 PNA equivalents were used to anneal the 
triplex. As shown in Appendix F, the reservoirs contained either 1.0 mL or 0.5 mL with 
either a 1:1 or 2:1 ratio of sample to buffer in the droplet. The different reservoir buffers 
tested were specifically chosen from successful crystallization work previously done by 
 JT Triplex
 JT Duplex
       JT-2+3     JT-2+3+p    JT-2+3+p  JT-2+3+p JT-2+3+p
300 µM 200 µM 225 µM 250 µM 300 µM
   JT-2+3                   JT-2+3+p             JT-2+3+p        JT-2+3+p                JT-2+3+p
300 µM 200 µM 225 µM 250 µM 300 µM
 JT Triplex
 JT Duplex
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post-doctorate researcher Meena. In her work, magnesium acetate, rather than zinc 
acetate was used in the reservoir buffers, so this substitution was made accordingly in an 
attempt to replicate her results. Initially after plating, all 24 wells were clear drops, but 
within three days, only well 4 showed any possibility of microcrystal formation, and after 
2.5 months, all wells had completely precipitated. 
Crystallization Plate 4 continued to probe the effect of altering sample to buffer 
ratio and reservoir volume, while also investigating whether a higher molecular weight 
PEG as precipitant or crystallizing agent could more successfully promote JT-2+3+p 
crystal growth (Appendix G). Returning to 300 µM triplex concentration annealed with 
10 mM HEPES, pH 7.0, 1 mM spermidine and 1.5 PNA equivalents, Plate 4 studied both 
PEG 8000 and PEG 10000. After plating, all drops appeared clear under microscope 
indicating no immediate precipitation was occurring. After six days, the droplet of well 
21 was characterized as a birefringent precipitate or microcrystals. Interestingly, well 21 
contained 30% PEG 8000 at pH 6.5, which had previously shown encouraging results in 
the first crystallization plate studied. This well, however, differed in two respects from 
Plate 1: 1.) it contained magnesium acetate rather than zinc acetate as additive, and 2.) the 
total reservoir volume was 0.5 mL rather than 1.0 mL. After eight days, four new wells 
were generated from the original droplet in an effort to increase crystal size. 0.25 µL of 
the original droplet was pipetted onto a new glass slide and mixed with 1.00 µL of buffer 
identical to that contained in the reservoir of well 21. It was hoped that repeating the 
process of reaching droplet-buffer equilibrium would promote the crystallization of JT 
triplex still in solution onto the microcrystal (acting as a sort of template). However, of 
these four wells, all had precipitated within two weeks without showing any increase in 
microcrystal size. 
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Based on the findings from Plates 1 and 4, crystallization plate 5 was dedicated 
exclusively to 30% PEG 8000, varying the pH (6.0, 6.5, 7.0, and 7.5) as well as sample to 
buffer ratio (1:1, 2:1, and 2:2) (Appendix H). Using 300 µM complex with 1.5 PNA 
equivalents, this plate showed complete precipitation after less than one week. 
Crystallization Plate 6 focused exclusively on the PEG 10000 at 4 different pHs and 4 
different PEG percentages, and alternating between zinc acetate and magnesium acetate 
as additive (Appendix I). Precipitation occurred in all 24 wells after about two months of 
incubation at 4°C without observation of any potential crystal formation. Crystallization 
plate 7 focused on the two well conditions which had proven most successful during 
previous crystallization work by Meena in the hopes of duplicating or improving on her 
results (Appendix J). The first buffer duplicated in wells 1-12 of Plate 7 contained 0.01 M 
Mg acetate, 0.2 M ammonium acetate, 0.05 M Na cacodylate, pH 6.0, and 35% PEG 
8000. The second buffer contained in wells 13-24 of Plate 7 was composed of 0.01 M Mg 
acetate, 0.2 M ammonium acetate, 0.05 M Na cacodylate, pH 6.5, and 25% PEG 4000. 
After almost two months, each of the PEG 8000 wells had precipitated, and the PEG 
4000 wells are still clear with no crystal formation yet observed. 
JW Sequences: As shown in Appendix C, the JW sequences were designed to have a 
non-complementary (C8-T8) target sequence flanked by 11 Watson-Crick base pairs 
similar to the JT sequences. However, the JW strands were distinguished by a single base 
overhang at the 5’ terminus (either A or T). When annealed as duplex or triplex, these 
single base overhangs would remain exposed, with the hope that the thymine overhang of 
one duplex would form a W-C base pair with the adenine overhang of a second duplex –
leaving an unpaired T and A still exposed at the 5’ termini (Figure 11). 
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(5’)   T GCA CCG ACG CGT TTT TTT  TCC GCG GCA GCC T GCA CCG ACG CGT TTT TTT  TCC GCG GCA GCC      (3’)
(3’)      CGT GGC TGC GCC CCC CCC CGG CGC CGT CGG A CGT GGC TGC GCC CCC CCC CGG CGC CGT CGG A (5’)
Figure 11: Laddering of JW Sequences (single JW duplex underlined)
This laddering effect was hoped to improve crystal formation by promoting the
aggrandizing of the macromolecule. One complication resulting from these overhangs, 
however, was the ability to visualize the JW duplex and triplex as a single, distinct band 
by gel electrophoresis to ensure complex formation. As seen in Figure 12, the JW strands 
showed gel streaking, indicative of the multiple molecular weight species formed by this 
laddering capacity. However, because laddering was ultimately desirable for 
crystallization purposes, streaking of non-denaturing gels was considered a positive and 
bearable result.
Figure 12: Duplex and Triplex Formation of JW Sequences at 300 µM
Again, prior to any crystallization work, it was first necessary to confirm the base 
composition and purity of the synthesized JW strands by 20% non-denaturing gel (Figure 
12, previous page). Lanes 2, 4, 6, and 8 contained annealed duplex, while lanes 3, 5, 7, 
JW-1+2     JW-1+2+p      JW-1+4     JW-1+4+p      JW-3+4     JW-3+4+p      JW-2+3     JW-2+3+p
 JW Triplex
 JW Duplex
21
and 9 contained annealed triplex. Duplex formation was visualized in all four lanes, and a 
higher molecular weight species indicative of triplex formation was observed in lanes 3 
and 5. The formation of very high molecular weight species in lanes 7 and 9, which 
subsequently could not migrate through the gel, may explain why these lanes appear 
washed out. JW duplexes were annealed with 25 mM HEPES, pH 7.0, 50 mM NaCl, 10 
mM MgCl2. JW triplexes were annealed with 25 mM HEPES, pH 7.0 (no spermidine). 
40 µL of 300 µM JW-1+2+p triplex containing 1.0 PNA equivalents was annealed 
with 25 mM HEPES, pH 7.0 for Crystallization Plate A. Because no successful 
crystallization work had ever been reported on these JW sequences, optimal 
crystallization conditions would have to be narrowed down from a general buffer set 
(Appendix K). For this plate, variables included pH (6.0, 6.5, 7.0, 7.5), PEG molecular 
weight (4000 or 8000), and PEG percentage (25%, 30%, 35%). Reservoir volume was 
held constant at 1 mL, and the droplet composition was 1 µL triplex solution and 1 µL 
well buffer. No precipitation was noted initially after plating. However, after three days, 
precipitation had occurred in all wells except 1, 7, 13, and 16, which remained as clear 
drops. While all 4 wells contained 25% PEG, three different pHs and both PEG 
molecular weights were represented, indicating that perhaps PEG concentration was the 
most important of the variables for the JW sequences. However, other wells containing 
25% PEG (i.e. wells 4, 10, and 22) on Plate A had precipitated, suggesting that PEG 
percentage alone does not dictate whether a solution will precipitate or crystallize. After 
2.5 months, wells 1, 7, 13, and 16 had also precipitated without producing any 
microcrystals. 
Using the exact same general set of reservoir buffers used in plate A, a second 
crystallization experiment (Plate B) was set up using the JW-1+4+p triplex (Appendix L). 
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Once again, 40 µL of 300 µM sample containing 1.0 PNA equivalents was annealed with 
25 mM HEPES, pH 7.0, and reservoir and droplet conditions were identical to plate A. 
Similar to Plate A, the samples showed no precipitation immediately after plating, but 
within three days, the majority had precipitated out of solution. Among those remaining 
as clear drops were wells 1, 4, 7, 10, 13, 16, 19, and 22 – representing a definite pattern 
of results. The reservoir buffer of each of these wells contained 25% PEG, with PEG 
molecular weight and pH once again varying. Unlike Plate A, every well containing a 
25% PEG concentration remained clear even after several months had passed. In fact, 
roughly eight months after plating, well 1 (25% PEG 4000, pH 6.0) and well 10 (25% 
PEG 8000, pH 6.5) contained the largest and most defined crystalline formations
observed on any plate. Unfortunately, at less than 0.2 mm, the crystals were not large 
enough to be analyzed by x-ray crystallography, but their existence holds promise for
future crystallization efforts, and suggests the significance of 25% PEG concentration in 
the crystallization of JW sequences. 
Looking collectively at the crystallization data from both the JT and JW strands, 
two things are readily apparent about research in this area of Janus Wedge triplexes: 1.) 
failures will always outweigh successes, and 2.) an ordered and systematic approach is 
essential if a three-dimensional structure is to be discovered. Without a doubt, the most 
promising results were contained in wells 1 and 10 of Plate B, but it was necessary to find 
a way to increase the crystal size in order for x-ray analysis to be possible. Subsequently, 
attempts were made to repeat this experiment using a more supersaturated solution. With 
more JW triplex in solution, it was hoped that there would be larger crystals forming out 
of solution. 40 µL of 350 µM JW-1+4+p triplex with 1.0 PNA equivalents was dried 
under high vacuum, and then annealed with 25 mM HEPES, pH 7.0. Addition of 
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annealing buffer, however, caused a large amount of the DNA to precipitate immediately. 
An additional 2.0 µL of annealing buffer along with 4.6 µL of 10 mM spermidine were 
added to dilute the complex to 300 µM. After filtering through a 0.22 µm Ultrafree-MC 
centrifugal filter at 10,000 rpm to eliminate residual triplex precipitates, sample was 
loaded onto a non-denaturing gel, which showed only faint laddering. Therefore, while 
increasing the complex concentration does increase the amount of triplex formed, it does 
so at the expense of the amount of triplex in solution. Because crystallization requires a 
supersaturated solution, increasing complex concentration beyond 300 µM does not 
appear to be a feasible means of increasing crystal size. 
Other methods of growing larger crystals are possible and must be explored in a 
systemized manner. For example, altering buffer composition may improve the solubility 
of the JW triplex, allowing for higher complex concentrations. In future experiments, 
previous crystallization efforts would be repeated using 10 mM spermine, which has 4 
positive charges per molecule, in the annealing buffer to possibly provide this added 
complex stability compared to spermidine, which has 3 positive charges. Additionally, if 
complex concentration cannot be stably increased above 300 µM, crystal growth can be 
improved through seeding experiments. Seeding involves taking a small amount of a 
microcrystal-containing droplet, such as those in wells 1 and 10 of Plate B, and forming a 
new droplet with buffer containing more triplex in solution. The seed crystal provides a 
template upon which the complex-containing solution may further crystallize. Typically, 
the degree of supersaturation required for seed formation is greater than that required for 
growth onto an existing crystal so complex concentration could be maintained at the 300 
µM level.
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Drew and Dickerson Dodecamer: Unlike Janus Wedge triplexes, three-
dimensional structures of complexes known as Drew and Dickerson dodecamers have 
been well-documented. Pioneered in the early 1980s by Drew and Dickerson at the 
California Institute of Technology, dodecamers have a d(CGCGAATTCGCG) sequence
and form self-complementary duplexes which form -form helices. Dickerson and Drew 
have obtained highly detailed data obtained by x-ray crystallography to 1.9 Å resolution 
of these duplexes.19 Their data reveals the interlocking of the minor grooves of 
neighboring molecules, the amount of bend in the helical axis, the base pairs per turn, and 
the mean propeller twist. 
Research by Loren D. Williams at the George Institute of Technology has 
provided even more detailed information about the interaction between -form 
dodecamer duplexes and other molecular species.20 Crystallization of the Drew and 
Dickerson sequence to 2.5 Å resolution revealed that within the A-T tract of the duplex, a 
spine of hydration partially composed of sodium ions is linked to a secondary spine of 
hydration. Furthermore, their diffraction patterns reveal a fully hydrated magnesium ion 
located in the major groove, suspected of interacting with cytosine bases of the duplex, as 
well as a partially ordered spermine molecule. 
High resolution crystallization has also been successful with modified Drew and 
Dickerson dodecamers. For example, Hossain et al. successfully crystallized a 
d(CGCGAATTmo4 CGCG)2 duplex, where mo4C is the modified base 2’-deoxy-N4-
methoxycytidine, by hanging drop vapor diffusion at 4°C.21 Analysis of the three-
dimensional structure showed that sequence modification does not disrupt -form helix
formation. Electron density maps also confirmed that the mo4C residue pairs with an 
opposite strand G with Watson-Crick type geometry. Crystallization buffer contained 
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28% (v/v) 2-methyl-2,4-pentanediol (MPD), 36 mM Mg acetate, 9 mM spermine 
tetrahydrochloride, and 20 mM sodium cacodylate, pH 7.0. 
Research is currently proceeding on a modified Dickerson dodecamer sequence 
synthesized and purified by post-graduate student Zhenhua. The d(CGCGAATTC*GCG) 
sequence contains a 2-amino-pyrimidine modified base at the C* residue. Crystallization 
efforts have been initiated using Hossain’s work with a mo4C modified base as a guide to 
crystallization. Dodecamer solutions have been annealed with 36 mM Mg acetate, 9 mM 
spermine tetrahydrochloride, and 20 mM sodium cacodylate at pH 6.6, 6.8, 7.0, and 7.2. 
Because of the high concentration of the pure dodecamer solution (603.56 µM), gel 
loading was done with only 0.10 µL of sample solution + 9.9 µL loading buffer 
(annealing buffer plus 30% glycerol). Visualization of the gel revealed no bands at all, 
which was reasonably interpreted as a consequence of the extremely small volume which 
was loaded. Even with a 2.5 µL pipet, 0.10 µL is at the lower extreme of its pipeting 
capacity, and it was surmised that accurate pipeting was not occurring. A follow-up gel 
will be run in which a larger volume of sample solution, which can be pipetted with 
certainty such as 0.5 µL, will be diluted to 2.5 µL with loading buffer. A 10 µL aliquot of 
this solution will have the same complex concentration as the solution loaded into the 
previous gel, but in this case, dilution will help overcome the limitations of the scientific 
equipment. As soon as Dodecamer duplex formation is confirmed by gel electrophoresis, 
a crystallization plate will be set up which has been designed based on the growing 
conditions of the Hossain crystal. Reservoir buffers of all 24 wells will contain 20 mM 
sodium cacodylate, 36 mM Mg acetate, and 9 mM spermine tetrahydrochloride. Samples 
will be either pH 6.6, 6.8, 7.0, or 7.2, and for each of the four pHs, MPD concentration 
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will be 20%, 22.5%, 25%, 26.5%, 28%, or 30% – consequently, each well will contain a 
unique buffer similar to the buffer used to crystallize the mo4C modified dodecamer.
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Appendix C: Synthesized Strands
Strand Name Sequence
JT-2 5’ –       GCA CCG ACG CGT TTT  TTT   TCC GCG GCA GCC         – 3’
JT-3    3’ –       CGT GGC TGC GCC CCC CCC CGG CGC CGT CGG         – 5’ 
JW-1    5’ –  T   GCA CCG ACG CGT TTT  TTT   TCC  GCG GCA GCC        – 3’ 
JW-2    3’ –       CGT GGC TGC GCC CCC CCC CGG CGC CGT CGG   A    – 5’
JW-3    5’ –  A   GCA CCG ACG CGT TTT  TTT  TCC  GCG GCA GCC         – 3’
JW-4    3’ –       CGT GGC TGC GCC CCC CCC CGG CGC CGT CGG   T    – 5’
Appendix B: Extinction Coefficients
Sample Extinction Coefficient (cm-1M-1)
G 11,500
T 8,700
C 7,400
A 15,400
2APy 1,500
JW-1 299,300
JW-2 287,300
JW-3 341,000
JW-4 280,700
JT-2 290,500
JT-3 271,900
M1-219 71,000
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Appendix D: Crystallization Plate 1
Well # Resevoir Buffer
1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.0
2 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 6.0
3 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 6.0
4 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 6.0
5 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.0
6 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
7 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
8 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 6.5
9 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 6.5
10 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 6.5
11 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.5
12 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.5
13 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 7.0
14 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 7.0
15 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 7.0
16 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 7.0
17 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.0
18 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 7.0
19 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 7.5
20 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 7.5
21 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 7.5
22 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 7.5
23 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
24 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 7.5
Appendix E: Crystallization Plate 2
Well # Conc (uM) Buffer
1 200 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 32.5% PEG 8000
2 200 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000
3 200 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 37.5% PEG 8000
4 200 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 40% PEG 8000
5 200 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 42.5% PEG 8000
6 200 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 45% PEG 8000
7 225 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 32.5% PEG 8000
8 225 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000
9 225 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 37.5% PEG 8000
10 225 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 40% PEG 8000
11 225 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 42.5% PEG 8000
12 225 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 45% PEG 8000
13 250 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 32.5% PEG 8000
14 250 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000
15 250 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 37.5% PEG 8000
16 250 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 40% PEG 8000
17 250 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 42.5% PEG 8000
18 250 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 45% PEG 8000
19 300 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 32.5% PEG 8000
20 300 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000
21 300 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 37.5% PEG 8000
22 300 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 40% PEG 8000
23 300 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 42.5% PEG 8000
24 300 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 45% PEG 8000
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Appendix F: Crystallization Plate 3
Well #
S:B 
Ratio
Res 
Vol Buffer
1 1 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 4000
2 1 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 4000
3 1 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 30% PEG 4000
4 1 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 35% PEG 4000
5 1 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.5, 30% PEG 4000
6 1 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.5, 25% PEG 8000
7 2 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 4000
8 2 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 4000
9 2 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 30% PEG 4000
10 2 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 35% PEG 4000
11 2 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.5, 30% PEG 4000
12 2 + 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.5, 25% PEG 8000
13 1 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 4000
14 1 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 4000
15 1 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 30% PEG 4000
16 1 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 35% PEG 4000
17 1 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.5, 30% PEG 4000
18 1 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.5, 25% PEG 8000
19 2 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 4000
20 2 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 4000
21 2 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 30% PEG 4000
22 2 + 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 7.0, 35% PEG 4000
Appendix G: Crystallization Plate 4
Well 
#
S:B 
Ratio
Res 
Vol Buffer
1 1+ 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 10000
2 2 + 2 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 10000
3 1+ 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 10000
4 2 + 2 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 30% PEG 10000
7 1+ 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 35% PEG 8000
8 2 + 2 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 35% PEG 8000
9 1+ 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 35% PEG 8000
10 2 + 2 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.0, 35% PEG 8000
13 1+ 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 25% PEG 10000
14 2 + 2 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 25% PEG 10000
15 1+ 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 25% PEG 10000
16 2 + 2 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 25% PEG 10000
19 1+ 1 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 8000
20 2 + 2 1 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 8000
21 1+ 1 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 8000
22 2 + 2 0.5 mL 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, pH 6.5, 30% PEG 8000
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Appendix H: Crystallization Plate 5
Well # S:B Ratio Buffer
1 1 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.0
2 2 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.0
3 2 + 2 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.0
7 1 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.5
8 2 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.5
9 2 + 2 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.5
13 1 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.0
14 2 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.0
15 2 + 2 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.0
19 1 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
20 2 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
21 2 + 2 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
22 1 + 1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
23 2 + 2 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
Appendix I: Crystallization Plate 6
Well # Buffer
1 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 20% PEG 10000, pH 6.5
2 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 20% PEG 10000, pH 7.0
3 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 20% PEG 10000, pH 7.5
4 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 20% PEG 10000, pH 6.5
5 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 20% PEG 10000, pH 7.0
6 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 20% PEG 10000, pH 7.5
7 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 10000, pH 6.5
8 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 10000, pH 7.0
9 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 10000, pH 7.5
10 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 10000, pH 6.5
11 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 10000, pH 7.0
12 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 10000, pH 7.5
13 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 10000, pH 6.5
14 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 10000, pH 7.0
15 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 10000, pH 7.5
16 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 10000, pH 6.5
17 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 10000, pH 7.0
18 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 10000, pH 7.5
19 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 10000, pH 6.5
20 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 10000, pH 7.0
21 0.01 M Zn acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 10000, pH 7.5
22 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 10000, pH 6.5
23 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 10000, pH 7.0
24 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 10000, pH 7.5
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Appendix J: Crystallization Plate 7
Well # Buffer
1 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
2 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
3 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
4 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
5 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
6 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
7 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
8 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
9 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
10 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
11 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
12 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
13 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
14 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
15 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
16 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
17 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
18 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
19 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
20 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
21 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
22 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
23 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
24 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
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Appendix K: Crystallization Plate A
Well # Buffer
1 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.0
2 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 6.0
3 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 6.0
4 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 6.0
5 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.0
6 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
7 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
8 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 6.5
9 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 6.5
10 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 6.5
11 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.5
12 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.5
13 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 7.0
14 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 7.0
15 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 7.0
16 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 7.0
17 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.0
18 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 7.0
19 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 7.5
20 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 7.5
21 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 7.5
22 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 7.5
23 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
24 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 7.5
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Appendix L: Crystallization Plate B
Well # Buffer
1 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.0
2 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 6.0
3 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 6.0
4 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 6.0
5 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.0
6 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.0
7 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 6.5
8 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 6.5
9 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 6.5
10 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 6.5
11 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 6.5
12 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 6.5
13 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 7.0
14 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 7.0
15 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 7.0
16 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 7.0
17 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.0
18 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 7.0
19 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 4000, pH 7.5
20 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 4000, pH 7.5
21 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 4000, pH 7.5
22 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 25% PEG 8000, pH 7.5
23 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 30% PEG 8000, pH 7.5
24 0.01 M Mg acetate, 0.2 M Amm acetate, 0.05 M Na cacodylate, 35% PEG 8000, pH 7.5
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